Clinical Ophthalmology
Volume 15, 2021 - Issue
Open access
131
Views
1
CrossRef citations to date
0
Altmetric
Original Research
Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Mayuresh Naik1 Department of Ophthalmology, H.I.M.S.R & H.A.H. Centenary Hospital, New Delhi, IndiaCorrespondence[email protected]
https://orcid.org/0000-0003-0368-042XView further author information
, https://orcid.org/0000-0003-0368-042XView further author information
Monika Kapur2 Department of Ophthalmology, School of Medical Sciences & Research, Sharda University, Greater Noid, Uttar Pradesh, IndiaView further author information
, VishnuSwarup Gupta1 Department of Ophthalmology, H.I.M.S.R & H.A.H. Centenary Hospital, New Delhi, IndiaView further author information
, HarinderSingh Sethi3 Department of Ophthalmology, V.M.M.C & Safdarjung Hospital, New Delhi, 110029, IndiaView further author information
& Kartikeya Srivastava3 Department of Ophthalmology, V.M.M.C & Safdarjung Hospital, New Delhi, 110029, IndiaView further author information
Pages 2683-2692
|
Published online: 24 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.